Quick Guide: Cutimed® Sorbact® and antimicrobial stewardship

Share this article

Quick Guide: Cutimed® Sorbact® and antimicrobial stewardship

Supported by Essity
15 July 2024

Antibiotics have been used for many years in wound care to treat spreading and systemic infections, in both acute and chronic wounds. However, the widespread use and misuse of antibiotics across medicine and other sectors has allowed the emergence of microbial strains with resistance to one or more antibiotics. 

Currently, none of the 43 antibiotics in clinical development or recently approved are sufficient to tackle the growing emergence and spread of antimicrobial resistance (AMR)1. Despite increasing awareness of the urgent threat of AMR, the world needs to combat antibiotic resistance in more ways than just with the formulation of new antibiotics. 

The United Nations and other international agencies estimate that, if no action is taken, antimicrobial drug-resistant diseases could cause 10 million deaths each year by 2050, costing £66 trillion3.

The solution to reducing and preventing further AMR is a multi-modal approach known as antimicrobial stewardship (AMS). This approach includes the following: 

  • Infection prevention
  • Using antimicrobial treatments sparingly to preserve their future effectiveness
  • Improving safety and quality of patient care4.

Download the full Quick Guide below.

Disclaimer: Supported by Essity
References

1WHO (2020) Antibacterial agents in clinical and preclincal development: an overview and analysis

2International Wound Infection Institute (2022) Wound Infection in Clinical Practice. Wounds International

3Interagency Coordinating Group on Antimicrobial Resistance (2019) No Time To Wait: Securing The Future From Drug-Resistant Infections. Report to the Secretary-General of the United Nations. Interagency Coordinating Group on Antimicrobial Resistance

4NICE, PHE (2019) Summary of antimicrobial prescribing guidance – managing common infections

5Gentili V, Gianesini S, Balboni PG et al (2013) Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™. Eur J Clin Microbiol Infect Dis 31(7): 1523-9

6Mosti G, Magliaro A, Mattaliano V et al (2015) Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care 24(3): 121-2

7Ljungh A, Yanagisawa N, Wadström T (2006) Using the principle of hydrophobic interaction to bind and remove wound bacteria. J Wound Care 15(4): 175-80

8Husmark J, Morgner B, Susilo YB, Wiegand C (2022) Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care 31(7): 560-570

9Susilo YB and Husmark J (2019) DACC coated wound dressing and endotoxin: Investigation on binding ability and effect on endotoxin release from gram-negative bacteria. EWMA

10Fletcher J, Edwards-Jones V, Fumarola S et al (2020) Best Practice Statement: Antimicrobial stewardship strategies for wound management. Wounds UK

11Rippon MG, Rogers AA, Ousey K (2021) Antimicrobial stewardship strategies in wound care: evidence to support the use of dialkylcarbamoyl chloride (DACC)-coated wound dressings. J Wound Care 30(4): 284-96

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.